Presence of a functional receptor for GLP-1 in osteoblastic cells, independent of the cAMP-linked GLP-1 receptor

Journal of Cellular Physiology

Volumn 225, Issue 2, 2010, Pages 585-592

  Nuche Berenguer, Bernardo ^a   Portal Núñez, Sergio ^b   Moreno, Paola ^a   González, Nieves ^a   Acitores, Alicia ^a   López Herradón, Ana ^b   Esbrit, Pedro ^b   Valverde, Isabel ^a   Villanueva Peñacarrillo, María L ^a  

^a UAM)   (Spain)

^b Bone and Mineral Metab Laboratory   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; GLUCAGON; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; GLUCAGON LIKE PEPTIDE 2; GLUCOSE; GLYCOSYLPHOSPHATIDYLINOSITOL; INCRETIN; INSULIN; IODINE 125; MITOGEN ACTIVATED PROTEIN KINASE; OSTEOCALCIN; OSTEOPROTEGERIN; TRANSCRIPTION FACTOR RUNX2; WNT PROTEIN; ADENYLATE CYCLASE; EXENDIN 4; FORSKOLIN; GLUCAGON LIKE PEPTIDE 1; GLUCAGON RECEPTOR; GLUCAGON-LIKE PEPTIDE-1 RECEPTOR; PARATHYROID HORMONE; PEPTIDE; PROTEIN BINDING; VENOM;

ANIMAL CELL; ARTICLE; BIOSYNTHESIS; BONE DEVELOPMENT; CANONICAL ANALYSIS; CONTROLLED STUDY; CROSS LINKING; ENZYME ACTIVITY; GENE EXPRESSION; GLUCOSE METABOLISM; HYDROLYSIS; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; RAT; SCATCHARD PLOT; TEMPERATURE; 3T3 CELL LINE; ANIMAL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM;

RATTUS;

3T3 CELLS; ADENYLATE CYCLASE; ANIMALS; COLFORSIN; CYCLIC AMP; GENE EXPRESSION REGULATION; GLUCAGON-LIKE PEPTIDE 1; GLUCAGON-LIKE PEPTIDE 2; HUMANS; MICE; OSTEOBLASTS; PARATHYROID HORMONE; PEPTIDES; PROTEIN BINDING; RATS; RECEPTORS, GLUCAGON; VENOMS;

EID: 77956496046     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22243     Document Type: Article

References (47)

1. Alcántara AI, Morales M, Delgado E, López-DelgadoMI, Clemente F, Luque MA, Malaisse WJ, Valverde I, Villanueva-Peñacarrillo ML. 1997. Exendin-4 agonist and exendine(9-39) amide antagonist of the GLP-1(7-36) amide effects in liver and muscle. Arch Biochem Biophys 341:1-7.
2. Arnés L, González N, Tornero-Esteban P, Sancho V, Acitores A, Valverde I, Delgado E, Villanueva-Peñacarrillo ML. 2008. Characteristics of GLP-1 and exendins action upon glucose transport and metabolism in type 2 diabetic rat skeletal muscle. Int J Mol Med 22:127-132.
3. Bollag RJ, Zhong Q, Phillips P, Min L, Zhong L, Cameron R, Mulloy AL, Rasmussen H, Qin F, Ding KH, Isales CM. 2000. Osteoblasts-derived cells express functional glucose-dependent insulinotropic peptide receptors. Endocrinology 141:1228-1235. (Pubitemid 32260466)
4. Bradford MM. 1976. A rapid and sensitive method for the quantization of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 72:248-254.
5. Clowes JA, Khosla S, Eastell R. 2005. Perspective potential role of pancreatic and enteric hormones in regulating bone turnover. J Bone Miner Res 9:1497-1506. (Pubitemid 41243538)
6. Creutzfeldt W. 2001. The entero-insular axis in type 2 diabetes. Incretins as therapeutic agents. Exp Clin Endocr Diab 109:288-303.
7. Delgado E, Luque MA, Alcántara A, Trapote MA, Clemente F, Galera C, Valverde I, Villanueva-Peñacarrillo ML. 1995. Glucagon-like peptide-1 binding to rat skeletal muscle. Peptides 16:225-229.
8. Galera C, Clemente F, Alcántara A, Trapote MA, Perea A, López-Delgado MI, Villanueva- Peñacarrillo ML, Valverde I. 1996. Inositolphosphoglycans and diacylglycerol are possible mediators in the glycogenic effect of GLP-1(7-36)amide in BC3H-1miocytes. Cell Biochem Funct 14:43-48. (Pubitemid 26055415)
9. Glass DA, Karsenty G. 2007. Minireview: In vivo analysis of wnt signalling in bone. Endocrinology 148:2630-2634.
10. Glass DA, Bialek P, Ahn JD. 2005. Canonical Wnt signalling in differentiated osteoblasts controls osteoclast differentiation. Dev Cell 8:751-764. (Pubitemid 40585297)
11. González N, Sancho V, Martín-Duce A, Tornero-Esteban P, Valverde I, Malaisse WJ, Villanueva-Peñacarrillo ML. 2005. GLP-1 signalling and effects on glucose metabolism in myocytes from type 2 diabetic patients. Int J Mol Med 16:747-752.
12. Hedo JA, Simpson IA. 1984. Internalization of insulin receptors in the isolated rat adipose cell. J Biol Chem 259:11083-11089.
13. Henriksen DB, Alexandersen P, Bjarnason NH, Vilsboll T, Hartmann B, Henriksen EE, Byrjalsen I, Krarup T, Holst JJ, Christiansen C. 2003. Role of gastrointestinal hormones in postprandial reduction of bone resorption. J Bone Miner Res 18:2180-2189. (Pubitemid 37463311)
14. Jackson A, Vayssière B, Garcia T, Newell W, Baron R, Roman-Roman S, Rawadi G. 2005. Gene array analysis of Wnt-regulated genes in C3H10T1/2 cells. Bone 4:585-598.
15. Jarett L, Seals JR. 1979. Pyruvate dehydrogenase activation in adipocyte mitochondria by an insulin-generated mediator from muscle. Science 206:1407-1408. (Pubitemid 10181465)
16. Jones DR, Varela-Nieto I. 1999. Diabetes and the role of inositol-containing lipids in insulin signaling. Mol Med 5:505-514. (Pubitemid 29483062)
17. Laemmli UK. 1970. Cleavage of structural proteins furing the assembly of the head of bacteriophage T4. Nature 227:680-685.
18. Larner J. 1988. Insulin signalling mechanisms. Lessons from the old testament of glycogen metabolism and the new testament of molecular biology. Diabetes 37:262-275.
19. Larner J, Galasko G, Chen K, DePAoli-Roach AA, Huang L, Daggy P, Kellog J. 1979. Generation by insulin of a chemical mediator that controls protein phophorylation and de phosphorylation. Science 206. 1408-1410. (Pubitemid 10181466)
20. Lozano DF, de Castro L, Dapía S, Andrade-Zapata I, Manzarbeitia F, Álvarez-Arroyo MV, Gómez-Barrena E, Esbrit P. 2009. Role of parathyroid hormone-related protein in the decreased osteoblast function in diabetes-related osteopenia. Endocrinology 150:2027-2035.
21. Luque MA, González N, Márquez L, Acitores A, Redondo A, Morales M, Valverde I, Villanueva-Peñacarrillo ML. 2002. Glucagon-like peptide-1 (GLP-1) and glucose metabolism in human myocytes. J Endocrinol 173:465-473.
22. Márquez L, Trapote MA, Luque MA, Valverde I, Villanueva- Peñacarrilo ML. 1998. Inositolphosphoglycans possibly mediate the effects of glucagon-like peptide 1(7-36) amide on rat liver and adipose tissue. Cell Biochem Funct 16:51-56.
23. Marshall S, Heidenreich KA, Horikoshi H. 1985. Stochiometric translocation of adipocyte insulin receptors from the cell-surface to the cell interior. Studies using a novel method to rapidly remove detergent and concentrate soluble receptors. J Biol Chem 260:4128-4135. (Pubitemid 15091956)
24. Montrose-Rafizadeh C, Yang H, Wang Y, Roth J, Montrose MH, Adams LG. 1997. Novel signal transduction and peptide specificity of glucagon-like peptide receptor in 3T3-L1 adipocytes. J Cell Physiol 172:275-283. (Pubitemid 27376193)
25. Müller G, Wied S, Piossek C, Bauer A, Bauer J, Frick W. 1998. Convergence and divergence of the signaling pathways for insulin and phosphoinositolglycans. Mol Med 4:299-323.
26. NishizawaM, Nakabayashi H, Kawai K, Ito T, Kawakami S, Nakagawa A,Niijima A, Uchida K. 2000. The hepatic vagal reception of intraportal GLP-1 is via receptor different from the pancreatic GLP-1 receptor. J Auton Nerv Syst 12:14-21. (Pubitemid 30160722)
27. Noguchi H, Oishi K, Ueda M, Yukawa H, Hayashi S, Kobayashi N, Levy MF, Matusmoto S. 2009. Establishment of mouse pancreatic stem cell line. Cell Transplant 18:563-571.
28. Nuche-Berenguer B, Moreno P, Esbrit P, Dapía S, Caeiro JR, Cancelas J, Haro-Mora JJ, Villanueva-Peñacarrillo ML. 2009. Effect of GLP-1 treatment on bone turnover in normal, type 2 diabetic and insulin-resistant states. Calcif Tissue Int 84:453-461.
29. Nuche-Berenguer B, Moreno P, Portal-Nuñez S, Dapía S, Esbrit P, Villanueva-Peñacarrillo ML. 2010. Exendin-4 exerts osteogenic actions in insulin-resistant and type 2 diabetic states. Regul Pept 159:61-66.
30. Pérez-Tilve D, González-Matías L, Alvarez-Crespo M, Leiras R, Tovar S, Diéguez C, Mallo F. 2007. Exendin-4 potently decreases ghrelin levels in fasting rats. Diabetes 56:143-151. (Pubitemid 46263128)
31. Saltiel AR, Cuatrecasas P. 1986. Insulin stimulates the generation from hepatic plasma membranes of modulators derived from an inositol glycolipid. Proc Natl Acad Sci USA 83:5793-5797. (Pubitemid 16000598)
32. Saltiel AR, Fox JA, Sherline P, Cuatrecasas P. 1986. Insulin stimulated hydrolysis of a novel glycolipid generates modulators of cAMP phosphodiesterase. Science 206:1408-1410.
33. Sancho V, Trigo MV, González N, Valverde I, Malaisse WJ, Villanueva-Peñacarrillo ML. 2005. Effects of GLP-1 and exendins on kinase activity, 2-deoxy-D-glucose transport, lipolysis and lipogenesis in adipocytes from normal and streptozotocin-induced type 2 diabetic rats. J Mol Endocrinol 35:27-38.
34. Simonsen L, Pilgaard S, Orskov C, Rosenkilde MM, Hartmann B, Holst JJ, Deacon CF. 2007. Exendin-4, but not dipeptidyl peptidase IV inhibition, increases small intestinal mass in GK rats. Am J Physiol Gastrointest Liver Physiol 293:G288-G295. (Pubitemid 47105178)
35. Spencer GJ, Utting JC, Etheridge SL, Arnett TR, Genever PG. 2006. Wnt signalling in osteoblasts regulates expression of the receptor activator of NFkappaB ligand and inhibits osteoclastogenesis in vitro. J Cell Sci 119:1283-1296.
36. Suzuki S, Toyota T, Suzuki H, Goto Y. 1984a. A putative secons messenger of insulin action regulates hepatic microsomal glucose-6-phosphatase. Biochem Biophys Res Comm 118:40-46. (Pubitemid 14191945)
37. Suzuki S, Toyota T, Suzuki H, Goto Y. 1984b. Partial purification from human mononuclear cells and placental plasma membranes of an insulin mediator which stimulates pyruvate dehydrogenase and suppresses glucose-6-phosphatase. Arch Biochem Biophys 235:418-426. (Pubitemid 15158798)
38. Thorens B. 1992. Expression clonning of the pancreatic beta-cell receptor for the glucoincretin hormone glucagon-like peptide-1. Proc Natl Acad Sci USA 89:8641-8645.
39. Valverde I,Mérida E, Delgado E, Trapote MA, Villanueva- Peñacarrillo ML. 1993. Presence and characterization of glucagon-like peptide-1(7-36)amide receptors in solubilized membranes of rat adipose tissue. Endocrinology 132:75-79. (Pubitemid 23019484)
40. Valverde I, Morales M, Clemente F, López-Delgado MI, Delgado E, Perea A, Villanueva- Peñacarrillo ML. 1994. Glucagon-like peptide-1: A potent glycogenic hormone. FEBS Lett 349:313-316. (Pubitemid 24263284)
41. Villanueva-Peñacarrillo ML, Alcántara AI, Clemente F, Delgado E, Valverde I. 1994. Potent glycogenic effect of GLP-1(7-36)amide in rat skeletal muscle. Diabetologia 37:1163-1166.
42. Villanueva-Peñacarrillo ML, Delgado E, Trapote MA, Alcántara AI, Clemente F, Luque MA Perea A, Valverde I. 1995. Glucagon-like peptide-1 binding to rat hepatic membranes. J Endocrinol 146:183-189.
43. Villanueva-Peñacarrillo ML, Puente J, RedondoA,Clemente F, Valverde I. 2001. Effect of GLP- 1 treatment on GLUT2 and GLUT4 expression in NIDDM and IDDM rats. Endocrine 15:241-248. (Pubitemid 32977337)
44. Willert K, Brown JD, Danenberg E, Duncan AW, Weissman IL, Reya T, Yates JR III, Nusse R. 2003. Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 423:448-452. (Pubitemid 36626997)
45. Xie D, Zhong Q, Ding KH, Cheng H, Williams S, Correa D, Bollag WB, Bollag RJ, Insogna K, Troiano N, Coady C, Hamrick M, Isales CM. 2007. Glucose-dependent insulinotropic peptide-overexpressing transgenic mice have increased bone mass. Bone 40:1352-1360. (Pubitemid 46566429)
46. Yamada C, Yamada Y, Tsukiyama K, Yamada K, UdagawaN, TakahashiN, Tanaka K, Drucker DJ, Seino Y, Inagaki N. 2008. The murine glucagon-like peptide-1 receptor is essential for control of bone resorption. Endocrinology 149:574-579. (Pubitemid 351159357)
47. Yang H, Egan JM, Wang Y, Moyes CD, Roth J, Montrose MH, Montrose-Rafizadeh C. 1998. GLP-1 action in L6 myotubes is via a receptor different from the pancreatic GLP-1 receptor. Am J Physiol 275:675-683.